Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-038135
Filing Date
2018-06-15
Accepted
2018-06-15 17:52:47
Documents
1
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3905
  Complete submission text file 0001209191-18-038135.txt   5306
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 AVENUE GENERAL DE GAULLE BRUXELLES C9 9999999999
Business Address
HILL STEPHEN A (Reporting) CIK: 0001237404 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 18903252